Institutional investors purchased a net $3.1 million shares of GSK during the quarter ended March 2015 and now own 10.44% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BARCLAYS CAPITAL, INC. Bought 5.0 Million shares of GlaxoSmithKline
RBC CAPITAL MARKETS LLC Bought 1.8 Million shares of GlaxoSmithKline
WELLS FARGO ADVISORS LLC Bought 1.2 Million shares of GlaxoSmithKline